Status:
COMPLETED
Extracorporeal Support for Respiratory Insufficiency (ECMO)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Acute Respiratory Failure
Lung Diseases
Eligibility:
All Genders
12-65 years
Phase:
PHASE3
Brief Summary
To evaluate indications for the use and efficacy of extracorporeal membrane oxygenators (ECMO's) for the support of patients with potentially reversible acute respiratory failure.
Detailed Description
BACKGROUND: The report of the Task Force on Respiratory Diseases identified a clinical syndrome of acute respiratory insufficiency (ARI) and estimated that approximately 60,000 Americans die of ARI y...
Eligibility Criteria
Men and women, ages 12 to 65, not stratified as to ethnic group, who had potentially reversible acute respiratory failure.
Key Trial Info
Start Date :
June 1 1974
Trial Type :
INTERVENTIONAL
End Date :
November 1 1979
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000562
Start Date
June 1 1974
End Date
November 1 1979
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.